RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announces the publication of “Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting” in PLoS ONE.
